Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Organ Preservation Market, By Solution
7.1. Organ Preservation Market, By Solution Type, 2020-2030
7.1.1. University of Wisconsin (UW)
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Custodial HTK
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Perfadex
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Others
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Organ Preservation Market, By Organ Type
8.1. Organ Preservation Market, By Organ Type, 2020-2030
8.1.1. Kidneys
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Liver
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Lung
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Heart
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Organ Preservation Market, By Preservation Technique
9.1. Organ Preservation Market, By Preservation Technique, 2020-2030
9.1.1. Static Cold Storage
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Hypothermic Machine Perfusion
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Normothermic Machine Perfusion
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Organ Preservation Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Solution (2016-2030)
10.1.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.1.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Solution (2016-2030)
10.1.4.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.1.4.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Solution (2016-2030)
10.1.5.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.1.5.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Solution (2016-2030)
10.2.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.2.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Solution (2016-2030)
10.2.4.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.2.4.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Solution (2016-2030)
10.2.5.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.2.5.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Solution (2016-2030)
10.2.6.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.2.6.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Solution (2016-2030)
10.2.7.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.2.7.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Solution (2016-2030)
10.3.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.3.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Solution (2016-2030)
10.3.4.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.3.4.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Solution (2016-2030)
10.3.5.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.3.5.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Solution (2016-2030)
10.3.6.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.3.6.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Solution (2016-2030)
10.3.7.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.3.7.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Solution (2016-2030)
10.4.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.4.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Solution (2016-2030)
10.4.4.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.4.4.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Solution (2016-2030)
10.4.5.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.4.5.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Solution (2016-2030)
10.4.6.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.4.6.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Solution (2016-2030)
10.4.7.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.4.7.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Solution (2016-2030)
10.5.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.5.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Solution (2016-2030)
10.5.4.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.5.4.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Solution (2016-2030)
10.5.5.2. Market Revenue and Forecast, By Organ Type (2016-2030)
10.5.5.3. Market Revenue and Forecast, By Preservation Technique (2016-2030)
Chapter 11. Company Profiles
11.1. XVIVO Perfusion
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. TransMedics
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. 21st Century Medicine
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. CryoLife, Inc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bridge to Life Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms